Ignite Creation Date:
2025-12-24 @ 12:38 PM
Ignite Modification Date:
2026-03-01 @ 8:51 PM
Study NCT ID:
NCT01186861
Status:
COMPLETED
Last Update Posted:
2025-11-18
First Post:
2010-08-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva®), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy
Sponsor:
Organization: